Health Care

BlackRock’s new voting‑right stake in Uniphar PLC boosts investor confidence, highlighting the company’s strategic growth in pharma and med‑tech.

Envista Holdings boosts growth prospects with JPMorgan upgrade, Aspire lens validation, and a 2031 $11B clear‑aligner boom – see how the company is set for stronger earnings.

Gerresheimer AG’s €1 bn debt‑backed divestiture and supportive AGM signal a focused turnaround for the specialty packaging firm—what it means for investors.

Japan’s Eisai secures China NMPA approval for Bioarctic subcutaneous auto‑therapy, boosting its foothold in the 7 % CAGR autoimmune uveitis market.

Discover how SEERS Co., Ltd. is reshaping South Korea’s medical device market with cutting‑edge holter ECGs and pulse oximeters, backed by a high‑growth P/E ratio.

Veeva launches Falcon Safety, a unified E2B‑compatible platform, and crowns ACTO a Gold Product Partner—boosting cloud‑based safety, compliance, and life‑sciences collaboration.

Valneva SE’s rising share price reflects strong vaccine innovation and potential Pfizer partnership, offering investors a unique opportunity in the biotech sector.

How Eli Lilly’s $2.88 billion Merida acquisition will reshape the autoimmune market, boosting revenue and outpacing rivals with next‑gen biologics.

We couldn’t find any news about Merck & Co. Inc., so a related article can’t be created without additional information.

Novartis stock jumps 6% as MS trial success and remibrutinib Phase III results boost investor confidence, amid a $3.2 bn licensing deal with Alteogen.